Precision BioSciences, Cellectis Settle Longtime Patent Feud
Precision BioSciences Inc. and Cellectis SA have reached a deal to cross-license certain genome engineering patents in order to settle ongoing litigation, the two biopharmaceutical companies said Thursday....To view the full article, register now.
Already a subscriber? Click here to view full article